Skip to main content
ConductScienceScienceDex

M. Imad Damaj

NIH Rank #7446
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1884461Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pharmacology

NIH Funding · FY2026

Linked Award Amount
$1.2M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#7,446
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for M. Imad Damaj. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing M. Imad Damaj as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA272147-04R01
    Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms
    Virginia Commonwealth University
    $568.6K
    award amount
  • 1R21DA062929-01A1R21
    Does Astrocyte Elevated Gene-1 (AEG-1), a Novel Transcriptional Regulator, Mediate an Anti-opioid System?
    Virginia Commonwealth University
    $426.9K
    award amount
  • 5R21CA296516-02R21
    Inhibition of NLRP3 inflammasome for the treatment of Chemotherapy-induced peripheral neuropathy
    Virginia Commonwealth University
    $217.7K
    award amount

Award organization

Organizations that administered FY2026 awards listing M. Imad Damaj as a PI.

FY2026 award administered by Virginia Commonwealth University (VA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Virginia Commonwealth University
  2. 2024
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2025
    R01 Grant Holder
  5. 2026
    $2M Cumulative Funding
  6. 2026
    Entered Top 50% Nationally
    Ranked #7446

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as M. Imad Damaj.

Dana E Selley
Virginia Commonwealth University
3
shared awards
Laura J Sim-selley
Virginia Commonwealth University
3
shared awards
Elizabeth Edmondson
Virginia Commonwealth University
2
shared awards
Hamid I Akbarali
Virginia Commonwealth University
1
shared award

Explore further

Find collaborators for M. Imad Damaj

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →